Condition
patch adhesion trial with healthy subjects, therapeutical indication not studied
Total Trials
2
Recruiting
0
Active
0
Completed
2
Key Insights
Highlights
Treatment Research
2 treatments under study, led by Tk254rx
Research Leaders
8 sponsors active, led by SocraTec R&D GmbH
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 2 trials
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 2 completed with results
Key Signals
Data Visualizations
Phase Distribution
2Total
Phase 1 (2)
Trial Status
Completed2
Clinical Trials (2)
Research Network
Common Treatments
- Tk254rx1
- Esflurbiprofen Topical System1
Active Sponsors
- SocraTec R&D GmbH2
- CRM Biometrics GmbH2
- Teikoku Seiyaku Co., Ltd.2
- SocraMetrics GmbH2
- ClinSearch1
Top Investigators
Teikoku Seiyaku Co., Ltd.
Related Conditions
- Healthy1
- Healthy Participants1